subject: UMLS:C5873038

subject_name: Insulin Human (inhaled)

object_name: type 2 diabetes mellitus


subject: UMLS:C5873038

object_name: Diabetes

tested_intervention: yes


subject: UMLS:C5873038

object_name: diabetes mellitus


subject: UMLS:C5873038

object_name: chronic obstructive pulmonary disease


subject: UMLS:C5873038

object_name: type 1 diabetes mellitus 1


subject: UMLS:C5873038

object_name: type 1 diabetes mellitus


subject: CHEBI:64089

subject_name: Vanoxerine

object_name: cocaine abuse

tested_intervention: unsure


subject: UMLS:C0061148


subject: CHEBI:177536

subject_name: Galeterone

object_name: prostate carcinoma


subject: CHEBI:177536

object_name: prostate cancer


subject: UNII:8375F9S90C

subject_name: Pamiparib

object_name: ovarian cancer


subject: UNII:8375F9S90C

object_name: ovarian neoplasm


subject: UNII:8375F9S90C

object_name: ovarian carcinoma


subject: UNII:8375F9S90C

object_name: carcinosarcoma


subject: CHEBI:231324

subject_name: alpelisib

object_name: head and neck squamous cell carcinoma


subject: CHEBI:231324

object_name: head and neck neoplasm


subject: UMLS:C2986399


subject: UMLS:C2986399


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib


subject: PUBCHEM.COMPOUND:135423438


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:195559

subject_name: Poziotinib


subject: CHEBI:195559


subject: UNII:Q8LVL5Z68H

subject_name: VAPENDAVIR

object_name: asthma


subject: UMLS:C4726944

subject_name: Vapendavir


subject: MESH:C000624167

subject_name: Utrogestan

object_name: Luteal Phase


subject: CHEBI:17026

subject_name: Progesterone


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Neck Carcinoma


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V

object_name: head and neck cancer


subject: UNII:7XL5ISS668

subject_name: Adcetris


subject: UNII:7XL5ISS668

object_name: non-small cell lung carcinoma


subject: UNII:7XL5ISS668

object_name: melanoma


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C5446584

subject_name: TAEK-VAC-HerBy Vaccine

object_name: chordoma


subject: UMLS:C5446584

object_name: HER2 positive breast carcinoma


subject: CHEBI:22198

subject_name: acetylcysteine

object_name: Acute Ischemic Stroke


subject: CHEBI:22198

object_name: Ischemic stroke


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: CHEBI:17561

subject_name: Cysteine


subject: CHEBI:17561


subject: UMLS:C3714648

subject_name: Vitamin K Drug Class

object_name: vitamin K measurement


subject: UMLS:C3541380

subject_name: Vitamin K containing hemostatics


subject: CHEBI:28384

subject_name: vitamin K


subject: CHEBI:18067

subject_name: Phylloquinone


subject: UMLS:C2936884

subject_name: Vitamin K [EPC]


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS

object_name: Sarcopenic obesity


subject: UMLS:C0770246

object_name: Presenile dementia


subject: UMLS:C0770246

object_name: dementia


subject: CHEBI:53796

subject_name: Levamlodipine

object_name: hypertension


subject: CHEBI:53796

object_name: Hypertension, CTCAE


subject: GTOPDB:7684

subject_name: lebrikizumab

object_name: atopic eczema


subject: CHEMBL.COMPOUND:CHEMBL1743035

subject_name: LEBRIKIZUMAB


subject: UMLS:C1881890


subject: UNII:S9J80L3D1U

subject_name: PELAREOREP

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UNII:S9J80L3D1U

object_name: Recurrent ovarian cancer


subject: UNII:S9J80L3D1U

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: acute respiratory distress syndrome


subject: CHEBI:68558

object_name: acute lung injury


subject: CHEBI:68558

object_name: pneumonia


subject: CHEBI:68558

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:68558

object_name: Hospital acquired pneumonia


subject: CHEBI:68558

object_name: Community-Acquired Pneumonia


subject: CHEBI:231614

subject_name: Nivolumab

object_name: triple-negative breast carcinoma


subject: UMLS:C2346820


subject: UNII:6ZJ8V3Q0H1

object_name: head and neck squamous cell carcinoma


subject: UNII:6ZJ8V3Q0H1


subject: UNII:6ZJ8V3Q0H1

object_name: non-small cell lung carcinoma


subject: UNII:X00B0D5O0E

subject_name: PIPERACILLIN

object_name: systemic inflammatory response syndrome


subject: UNII:X00B0D5O0E

object_name: Sepsis


subject: UNII:X00B0D5O0E

object_name: septic shock


subject: UNII:X00B0D5O0E

object_name: Sepsis, CTCAE


subject: CHEBI:8232

subject_name: Piperacillin


subject: CHEBI:8232


subject: CHEBI:8232


subject: CHEBI:8232


subject: CHEBI:9421

subject_name: Tazobactam


subject: CHEBI:9421


subject: CHEBI:9421


subject: CHEBI:9421


subject: PUBCHEM.COMPOUND:16119086

object_name: attention deficit hyperactivity disorder, inattentive type


subject: PUBCHEM.COMPOUND:16119086


subject: UNII:G3QE979K1X


subject: UNII:G3QE979K1X


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: Pediatric acute-onset neuropsychiatric syndrome


subject: UMLS:C0085297

object_name: PANDAS


subject: PUBCHEM.COMPOUND:9296

subject_name: treosulfan

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:9296

object_name: acute myeloid leukemia


subject: CHEBI:5050

subject_name: Fexofenadine

object_name: Heartburn


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: Hepatitis D, Chronic


subject: CHEBI:95001

subject_name: Dalcetrapib

object_name: acute coronary syndrome


subject: CHEBI:131327

object_name: malaria


subject: CHEBI:2674

subject_name: Amodiaquine


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: asbestosis


subject: CHEBI:74705

subject_name: Met-Leu

object_name: atopic conjunctivitis


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: MESH:C000722927

object_name: breast neoplasm


subject: UMLS:C1701155

subject_name: Mintox Maximum Strength

object_name: HIV infection


subject: CHEBI:68845

subject_name: Azilsartan medoxomil

object_name: Hypertension, CTCAE


subject: CHEBI:37845

subject_name: growth hormone

object_name: Dwarfism


subject: CHEBI:37845

object_name: Short stature


subject: CHEBI:37845

object_name: Short Stature, CTCAE


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: PUBCHEM.COMPOUND:170907453


subject: PUBCHEM.COMPOUND:170907453


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: PR:000007968

subject_name: somatotropin


subject: PR:000007968


subject: PR:000007968


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: outcomes general quality of life


subject: CHEBI:192614

object_name: Perceived quality of life


subject: CHEBI:192614

object_name: Good quality of life


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:9139


subject: UMLS:C1268855

subject_name: Gonadotropin releasing hormone antagonist

object_name: female infertility


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist


subject: CHEBI:75551

object_name: Drug Interactions


subject: CHEBI:75551

object_name: Adverse drug interaction


subject: CHEBI:9654

subject_name: Trazodone

object_name: endogenous depression


subject: CHEBI:9654

object_name: major depressive disorder


subject: CHEBI:233475

object_name: Plexosarcoma


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:27953

subject_name: Physostigmine

object_name: Upper airway obstruction


subject: PUBCHEM.COMPOUND:6918224

subject_name: QUETIAPINE FUMARATE

object_name: borderline personality disorder


subject: CHEBI:8707

subject_name: Quetiapine


subject: CHEBI:50692

subject_name: Mifepristone

object_name: Cushing syndrome


subject: CHEBI:50692

object_name: hyperaldosteronism


subject: CHEBI:73647

subject_name: Pro-Pro-Pro

object_name: osteoarthritis, knee


subject: CHEBI:134718

subject_name: Safinamide

object_name: Parkinson disease


subject: UMLS:C1135138

object_name: renal cell carcinoma


subject: CHEBI:5002

subject_name: Fenoldopam

object_name: chronic kidney disease


subject: CHEBI:5002

object_name: Chronic uremia


subject: CHEBI:5002

object_name: acute kidney failure


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: Post-Operative Pain


subject: PUBCHEM.COMPOUND:54675783

object_name: chronic pain (diagnosis)


subject: PUBCHEM.COMPOUND:54675783

object_name: Chronic pain


subject: PR:000007786

subject_name: glutamate decarboxylase 2

object_name: Diabetes, Autoimmune


subject: PR:000007786

object_name: type 1 diabetes mellitus


subject: UMLS:C3714501

subject_name: Insulin Drug Class


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:6375

subject_name: Lansoprazole


subject: CHEBI:6375


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Conn's syndrome


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: hemorrhoid


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:36467

subject_name: Ciguatoxins

object_name: Ewing sarcoma


subject: CHEBI:204928

subject_name: Cefotaxime


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UMLS:C5574748

subject_name: C-Terminal Telopeptide Type 1 Collagen, human


subject: UMLS:C0010377

subject_name: Crotoxin


subject: UniProtKB:P41416

subject_name: CXOL_NPVAC Conotoxin-like peptide (sprot)


subject: UMLS:C0305163

subject_name: Adriamycin PFS


subject: CHEBI:28748

subject_name: Doxorubicin


subject: UMLS:C0733688


subject: CHEBI:4911

subject_name: Etoposide


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Stage III Colon Cancer AJCC v7


subject: UNII:KXG2PJ551I

object_name: Stage III Colon Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Stage III Colon Cancer


subject: UNII:KXG2PJ551I

object_name: Microsatellite Instability


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:166975

subject_name: soybean oil

object_name: type 2 diabetes mellitus


subject: CHEBI:166975

object_name: Insulin resistance


subject: CHEBI:166975

object_name: Insulin Sensitivity


subject: DRUGBANK:DB09422

subject_name: Soybean oil


subject: DRUGBANK:DB09422


subject: DRUGBANK:DB09422


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: familial hemolytic anemia


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:28729

subject_name: alpha-D-mannose

object_name: Physiological Stress


subject: CHEBI:37684

subject_name: mannose


subject: CHEBI:4208

subject_name: D-mannopyranose


subject: UMLS:C4759829

object_name: Colon Neoplasm


subject: UMLS:C4759829

object_name: colorectal neoplasm


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: mixed glioma


subject: UMLS:C0919079

object_name: Adult Mixed Glioma


subject: UMLS:C0919079

object_name: ependymoma


subject: UMLS:C0919079

object_name: childhood ependymoma


subject: UMLS:C0919079

object_name: Newly Diagnosed Childhood Ependymoma


subject: UMLS:C0919079

object_name: Adult Ependymoma


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:83766

subject_name: Olaparib

object_name: Adverse effect of radiation therapy


subject: CHEBI:83766

object_name: Malignant neoplasm of female breast


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: musculoskeletal system disorder


subject: UNII:1C6V77QF41

object_name: Sarcopenic obesity


subject: UNII:1C6V77QF41

object_name: Inflammation


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: UNII:KV1M7Q3CBP

object_name: myeloproliferative neoplasm


subject: UNII:KV1M7Q3CBP

object_name: Malignant myeloproliferative neoplasm


subject: UNII:KV1M7Q3CBP

object_name: acute leukemia


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Metastatic malignant neoplasm to liver


subject: GTOPDB:9758

object_name: pancreatic neoplasm


subject: GTOPDB:9758

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:9758

object_name: malignant pancreatic neoplasm


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: CHEBI:201674

subject_name: Icaritin

object_name: liver carcinoma


subject: UMLS:C0350411

subject_name: Oxygen only product in gas for inhalation

object_name: transposition of the great arteries


subject: UNII:UM2XKY25DH

subject_name: NORELGESTROMIN

object_name: Menstrual disorder


subject: UNII:UM2XKY25DH

object_name: Dysmenorrhea, CTCAE


subject: UNII:UM2XKY25DH

object_name: Dysmenorrhea


subject: MESH:C511292

subject_name: Ortho Evra


subject: MESH:C511292


subject: MESH:C511292


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: prostate carcinoma


subject: CHEBI:4026

object_name: prostate cancer


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:64816

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:64816

object_name: Recurrent ovarian cancer


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: Retinal anomalies


subject: CHEBI:8093

object_name: Premature birth


subject: CHEBI:8093

object_name: premature birth (history)


subject: UMLS:C3896762

object_name: endometrial cancer


subject: UMLS:C3896762

object_name: uterine corpus cancer


subject: UMLS:C3896762

object_name: endometrial carcinoma


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: Infection


subject: UNII:Q46947FE7K

object_name: infectious disease


subject: UNII:Q46947FE7K

object_name: Adverse Event Associated with Infection


subject: UMLS:C2745868

subject_name: TMC 435


subject: UMLS:C2745868


subject: UMLS:C2745868


subject: UMLS:C2745868

object_name: chronic hepatitis C virus infection


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: inflammatory bowel disease


subject: CHEBI:6950

object_name: endogenous depression


subject: CHEBI:6950

object_name: major depressive disorder


subject: CHEBI:135948

subject_name: Amifampridine

object_name: spinal muscular atrophy


subject: RXCUI:8375

subject_name: placebo Oral Tablet


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Myelodysplasia, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2108975

subject_name: ANCESTIM

object_name: Myelodysplasia


subject: CHEMBL.COMPOUND:CHEMBL2108975


subject: UMLS:C0538777

subject_name: ancestim


subject: UMLS:C0538777


subject: CHEBI:2663

subject_name: Amiodarone

object_name: heart failure


subject: CHEBI:2663

object_name: Heart Failure, CTCAE


subject: CHEBI:2663

object_name: congestive heart failure


subject: CHEBI:2663

object_name: cardiac conduction defect


subject: CHEBI:2663

object_name: cardiovascular disorder


subject: CHEBI:2663

object_name: heart disorder


subject: CHEBI:2663

object_name: Arrhythmia


subject: UNII:QX45B99R3J

subject_name: Mavacamten

object_name: hypertrophic cardiomyopathy


subject: PUBCHEM.COMPOUND:222898

subject_name: Amphedrine

object_name: attention deficit hyperactivity disorder, inattentive type


subject: PUBCHEM.COMPOUND:222898


subject: CHEBI:42724

subject_name: levamfetamine


subject: CHEBI:42724


subject: CHEBI:132233

subject_name: Amphetamine


subject: CHEBI:132233


subject: CHEBI:5856

subject_name: Ibutilide

object_name: long QT syndrome


subject: CHEBI:5856

object_name: familial long QT syndrome


subject: CHEBI:5856

object_name: Prolonged QT interval


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:17026


subject: CHEBI:17026


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C2757070


subject: UMLS:C2757070


subject: CHEBI:84094

subject_name: testosterone sulfate


subject: CHEBI:84094


subject: CHEBI:84094


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: UMLS:C0962969

subject_name: RAD 001

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:23594367

subject_name: Boceprevir

object_name: chronic hepatitis C virus infection


subject: UNII:67RM91WDHQ

subject_name: Onvansertib

object_name: metastatic colorectal cancer


subject: UNII:67RM91WDHQ

object_name: colorectal cancer


subject: UNII:67RM91WDHQ

object_name: colorectal carcinoma


subject: UNII:67RM91WDHQ

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:7496

subject_name: Nelfinavir

object_name: glioma


subject: CHEBI:7496

object_name: malignant glioma


subject: UMLS:C1815442

subject_name: Travatan Z

object_name: open-angle glaucoma


subject: UMLS:C1815442

object_name: ocular hypertension


subject: UMLS:C1815442

object_name: Ocular hypertension


subject: GTOPDB:437

object_name: alopecia


subject: GTOPDB:437

object_name: Alopecia, CTCAE


subject: UMLS:C0950716


subject: UMLS:C0950716


subject: UMLS:C4305824

object_name: type 1 diabetes mellitus 1


subject: UMLS:C4305824

object_name: type 1 diabetes mellitus


subject: CHEBI:174615

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:174615

object_name: childhood myelodysplastic syndrome


subject: CHEBI:174615

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: MESH:C016752

subject_name: smecta

object_name: diarrhea


subject: UMLS:C0163748

subject_name: Diosmectite


subject: CHEBI:133354

subject_name: Bentonite


subject: UMLS:C1327996

subject_name: Transgenic Lymphocyte Immunization Vaccine

object_name: prostate cancer


subject: UMLS:C1327996

object_name: prostate neoplasm


subject: UMLS:C0699319

subject_name: Cytoxan

object_name: liver carcinoma


subject: UMLS:C0699319

object_name: hepatoblastoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: viral disease


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C5555041

subject_name: Emfizatamab

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UMLS:C5555041

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5555041

object_name: non-Hodgkin lymphoma


subject: UMLS:C5555041

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C5555041

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:1FQ2RY5YHH

subject_name: Patiromer

object_name: heart failure


subject: UNII:1FQ2RY5YHH

object_name: Heart Failure, CTCAE


subject: UNII:1FQ2RY5YHH

object_name: Hyperkalemia, CTCAE


subject: UNII:1FQ2RY5YHH

object_name: Hyperkalemia


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: hypotension


subject: CHEBI:8093

object_name: Hypotension, CTCAE


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:149504


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Refractory Transformed Chronic Lymphocytic Leukemia


subject: CHEBI:4026

object_name: Recurrent Transformed Chronic Lymphocytic Leukemia


subject: CHEBI:4026

object_name: Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma


subject: CHEBI:4026

object_name: Refractory Transformed Non-Hodgkin Lymphoma


subject: CHEBI:4026

object_name: Refractory Transformed B-Cell Non-Hodgkin Lymphoma


subject: CHEBI:4026

object_name: Recurrent Transformed B-Cell Non-Hodgkin Lymphoma


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: DRUGBANK:DB16582

subject_name: Lisocabtagene maraleucel


subject: DRUGBANK:DB16582


subject: DRUGBANK:DB16582


subject: DRUGBANK:DB16582


subject: DRUGBANK:DB16582


subject: DRUGBANK:DB16582

object_name: Non-Hodgkin's lymphoma transformed recurrent


subject: DRUGBANK:DB16582


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UMLS:C1541526

object_name: pancreatic neoplasm


subject: UMLS:C1541526

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1541526

object_name: malignant pancreatic neoplasm


subject: CHEBI:8892

object_name: arteriosclerosis disorder


subject: CHEBI:8892

object_name: atherosclerosis


subject: CHEBI:8892

object_name: HIV infection


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Hyperuricemia


subject: CHEBI:40279

object_name: Hyperuricemia, CTCAE


subject: CHEBI:40279

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:75551


subject: CHEBI:75551


subject: CHEBI:75551


subject: CHEBI:31596

subject_name: Febuxostat


subject: CHEBI:31596


subject: CHEBI:31596


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: hypoplastic left heart syndrome


subject: CHEBI:4466

object_name: tricuspid atresia


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: MESH:C000618349

subject_name: ALKS 5461

object_name: endogenous depression


subject: MESH:C000618349

object_name: major depressive disorder


subject: CHEBI:567361

subject_name: Cladribine

object_name: adult acute myeloid leukemia


subject: CHEBI:567361

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:567361

object_name: Recurrent Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: gastric adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: recurrent gastric cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Malignant neoplasm of stomach stage IV


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIB Gastric Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIC Gastric Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIA Gastric Carcinoma


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:66903

subject_name: Vismodegib


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:66903


subject: UMLS:C5690696

subject_name: MitoQ

object_name: peripheral vascular disease


subject: UMLS:C5690696

object_name: peripheral arterial disease


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Advanced breast cancer


subject: CHEBI:45863

subject_name: Paclitaxel


subject: PR:000001379

object_name: autoimmune hepatitis


subject: PR:000001379

object_name: Crohn disease


subject: PR:000001379

object_name: Behcet disease


subject: PR:000001379

object_name: Takayasu arteritis


subject: PR:000001379

object_name: autoimmune thrombocytopenia


subject: PR:000001379

object_name: autoimmune thrombocytopenic purpura


subject: PR:000001379

object_name: EXCESS LMW-DNA


subject: PR:000001379

object_name: granulomatosis with polyangiitis


subject: PR:000001379

object_name: ankylosing spondylitis


subject: PR:000001379

object_name: sclerosing cholangitis


subject: PR:000001379

object_name: primary sclerosing cholangitis


subject: PR:000001379

object_name: ulcerative colitis


subject: PR:000001379

object_name: inflammatory bowel disease 1


subject: PR:000001379

object_name: rheumatoid arthritis


subject: PR:000001379

object_name: systemic sclerosis


subject: PR:000001379

object_name: psoriasis


subject: PUBCHEM.COMPOUND:129678

subject_name: Pelubiprofen

object_name: Acute low back pain


subject: CHEBI:31970


subject: CHEBI:77069

subject_name: Eperisone


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Small cell lung cancer extensive stage


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: GTOPDB:12517

subject_name: tafolecimab


subject: CHEMBL.COMPOUND:CHEMBL4594554

subject_name: TAFOLECIMAB


subject: UMLS:C5419329

subject_name: Tafolecimab


subject: CHEBI:8499

subject_name: Propranolol

object_name: Drug Resistant Epilepsy


subject: PUBCHEM.COMPOUND:70701990

object_name: hepatitis C


subject: CHEBI:64816

object_name: glioblastoma


subject: CHEBI:64816

object_name: Childhood Glioblastoma


subject: CHEBI:64816

object_name: adult glioblastoma


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:71219

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:71219

object_name: sarcoma


subject: CHEBI:71219

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:71219

object_name: soft tissue sarcoma


subject: CHEBI:35553

subject_name: Perhexiline

object_name: diastolic heart failure


subject: CHEBI:93274

subject_name: Fluvoxamine

object_name: severe acute respiratory syndrome


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:6801


subject: CHEBI:2704

subject_name: Anastrozole

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:2704

object_name: pulmonary hypertension


subject: CHEBI:2704

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:2704

object_name: pulmonary arterial hypertension


subject: CHEBI:187893

subject_name: Baclofen

object_name: pervasive developmental disorder


subject: CHEBI:187893

object_name: autism


subject: CHEBI:187893

object_name: autism spectrum disorder


subject: GTOPDB:12989

subject_name: toripalimab

object_name: lip and oral cavity carcinoma


subject: GTOPDB:12989

object_name: oral cavity cancer


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Cryotherapy effect


subject: CHEBI:22586

subject_name: antioxidant

object_name: cardiovascular disorder


subject: CHEBI:22586

object_name: cancer


subject: CHEBI:22586

object_name: neoplasm


subject: UMLS:C0003402

subject_name: Antioxidants


subject: UMLS:C0003402


subject: UMLS:C0003402


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Secondary Glioblastoma


subject: CHEBI:231679

object_name: IDH-wildtype glioblastoma


subject: CHEBI:231679

object_name: Diffuse Glioma


subject: CHEBI:231679

object_name: astrocytoma, IDH-mutant, grade 4


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:CD7WXM716P

object_name: heart failure


subject: UNII:CD7WXM716P

object_name: Heart Failure, CTCAE


subject: UNII:CD7WXM716P

object_name: ischemic cardiomyopathy


subject: CHEBI:33322

subject_name: Rubidium


subject: CHEBI:33322


subject: CHEBI:33322


subject: UMLS:C2744646

object_name: Childhood Breast Carcinoma


subject: UMLS:C2744646

object_name: breast carcinoma


subject: UMLS:C2744646

object_name: breast cancer


subject: DRUGBANK:DB17545

subject_name: Jaktinib

object_name: atopic eczema


subject: UMLS:C4733234

subject_name: indium In 111 HER2-specific high-affinity protein ABY-025


subject: UMLS:C4733234


subject: UMLS:C4733234


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin


subject: PUBCHEM.COMPOUND:73151030


subject: PUBCHEM.COMPOUND:73151030

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:73151030

object_name: obesity


subject: PUBCHEM.COMPOUND:73151030

object_name: Obesity, CTCAE


subject: CHEBI:42797

subject_name: Gabapentin

object_name: focal epilepsy


subject: UNII:EXL0L74IKU

object_name: HIV infection


subject: CHEBI:94489

object_name: rheumatoid arthritis


subject: UMLS:C4725934

subject_name: Encochleated Amphotericin B

object_name: vulvovaginal candidiasis


subject: UMLS:C4725934

object_name: vulvovaginitis


subject: UMLS:C4725934

object_name: vaginitis


subject: UMLS:C4725934

object_name: Vaginal Yeast Infections


subject: UMLS:C4725934

object_name: Yeast infection


subject: PR:000049739

subject_name: calmodulin (rat)


subject: PR:000049739


subject: PR:000049739


subject: PR:000049739


subject: PR:000049739


subject: PR:000049738

subject_name: calmodulin (mouse)


subject: PR:000049738


subject: PR:000049738


subject: PR:000049738


subject: PR:000049738


subject: UniProtKB:P0DP24

subject_name: CALM2_HUMAN Calmodulin-2 (sprot)


subject: UniProtKB:P0DP24


subject: UniProtKB:P0DP24


subject: UniProtKB:P0DP24


subject: UniProtKB:P0DP24


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: Venous thrombosis after immobility


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:75551

object_name: type 2 diabetes mellitus


subject: CHEBI:5494

subject_name: ritropirronium bromide

object_name: chronic obstructive pulmonary disease


subject: UMLS:C2698843

subject_name: Macrogol 3350-Based Iso-Osmotic Laxative

object_name: colorectal carcinoma


subject: UMLS:C2698843

object_name: Adenomatous Polyps


subject: CHEBI:139072

object_name: Religious Affiliation - Meditation


subject: CHEBI:8614

subject_name: Psilocybin


subject: UNII:WN1479YT50

subject_name: Tecarfarin

object_name: Thromboembolism


subject: UNII:WN1479YT50

object_name: Blood Clot


subject: UNII:WN1479YT50

object_name: thrombosis


subject: UNII:WN1479YT50

object_name: Thrombosis of blood vessel


subject: CHEBI:2668

subject_name: Amlodipine

object_name: hyperaldosteronism


subject: CHEBI:2668

object_name: Mineralocorticoid Excess


subject: CHEBI:31547

subject_name: Eplerenone

object_name: hypertension


subject: CHEBI:31547

object_name: Hypertension, CTCAE


subject: CHEBI:31547


subject: CHEBI:31547


subject: CHEBI:231614

subject_name: Nivolumab

object_name: malignant pleural mesothelioma


subject: UMLS:C2346820


subject: UNII:LA585UM8DE

subject_name: asundexian

object_name: atrial fibrillation


subject: UNII:LA585UM8DE

object_name: Atrial Fibrillation by ECG Finding


subject: UNII:LA585UM8DE

object_name: Atrial Fibrillation, CTCAE


subject: DRUGBANK:DB19088

subject_name: Asundexian


subject: DRUGBANK:DB19088


subject: DRUGBANK:DB19088


subject: CHEBI:4469

subject_name: dexamfetamine

object_name: Compulsion


subject: UNII:W0UTB622GK

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:W0UTB622GK

object_name: obesity


subject: UNII:W0UTB622GK

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:124121703

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:124121703

object_name: non-Hodgkin lymphoma


subject: UMLS:C4526664


subject: UMLS:C4526664


subject: UMLS:C4721901

subject_name: Lanreotide Autogel

object_name: acromegaly


subject: UMLS:C4721901

object_name: Acral overgrowth


subject: CHEBI:141427

subject_name: Asp-Thr

object_name: Immunization reaction


subject: UMLS:C0086126


subject: UMLS:C2984509

subject_name: Diphtheria Toxoid/Tetanus Toxoid Vaccine Adsorbed


subject: CHEBI:17748

subject_name: Thymidine


subject: CHEBI:4728

subject_name: Dyphylline


subject: PR:000031275

subject_name: dystonin


subject: PR:000006321

subject_name: L-dopachrome tautomerase


subject: UMLS:C1579314

subject_name: Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed


subject: UMLS:C3526553

subject_name: diphtheria, tetanus toxoids and acellular pertussis vaccine


subject: CHEBI:136051

subject_name: Lusutrombopag

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: CHEBI:136051

object_name: aplastic anemia


subject: CHEBI:136051

object_name: idiopathic aplastic anemia


subject: CHEBI:85990

subject_name: Panobinostat

object_name: Solid Neoplasm


subject: CHEBI:85990

object_name: non-small cell lung carcinoma


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: carcinoma


subject: CHEBI:6129

subject_name: Ketorolac

object_name: arthroplasty; complications


subject: CHEBI:6129

object_name: Arthritis of knee


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:46195


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:75722


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:28918


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: Feeding disorder of infancy OR early childhood


subject: UMLS:C4547597

object_name: mild neurocognitive disorder


subject: UMLS:C4547597

object_name: mild cognitive impairment


subject: UMLS:C4547597

object_name: Alzheimer disease


subject: CHEBI:600103

subject_name: daptomycin

object_name: bacteriemia


subject: CHEBI:600103

object_name: Bacteremia, CTCAE


subject: CHEBI:39867

subject_name: Valproic acid

object_name: post-traumatic stress disorder


subject: CHEBI:39867

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Hallux valgus AND bunion


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:6931

subject_name: Midazolam

object_name: Sedation


subject: CHEBI:6931

object_name: Sedated


subject: CHEBI:6931


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:8802


subject: CHEBI:8802


subject: CHEBI:136519

subject_name: n-butyl isocyanate

object_name: HIV-1 infection


subject: PUBCHEM.COMPOUND:21130

subject_name: imidazole mustard


subject: PUBCHEM.COMPOUND:129130827

subject_name: Bictegravir


subject: UNII:A9A0O6FB4H

subject_name: Lenacapavir


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: cancer


subject: PUBCHEM.COMPOUND:4868

subject_name: polymyxin B

object_name: atopic eczema


subject: PUBCHEM.COMPOUND:4868

object_name: dermatitis


subject: PUBCHEM.COMPOUND:4868

object_name: Eczema, CTCAE


subject: UMLS:C0001714

subject_name: polymyxin B sulfate


subject: UMLS:C0001714


subject: UMLS:C0001714


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:116735

subject_name: Benzocaine


subject: CHEBI:116735


subject: CHEBI:116735


subject: CHEBI:74460

subject_name: Clioquinol


subject: CHEBI:74460


subject: CHEBI:74460


subject: CHEBI:15365

subject_name: Aspirin

object_name: Inflammation


subject: CHEBI:37941

subject_name: Clopidogrel


subject: CHEBI:37941

object_name: HIV infection


subject: CHEBI:31413

subject_name: Clobazam

object_name: Dravet syndrome


subject: CHEBI:31413

object_name: developmental and epileptic encephalopathy, 6A


subject: CHEBI:135515

subject_name: Bendamustine

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C4732934

subject_name: Vincristine Sulfate Liposome Injection, USP

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C4732934

object_name: MALT lymphoma


subject: UMLS:C4732934

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C4732934

object_name: follicular lymphoma


subject: UMLS:C4732934


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: Control of hip fracture risk


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:60802

object_name: hip fracture


subject: PUBCHEM.COMPOUND:4240

subject_name: Mometasone furoate

object_name: Multiple polyps of nasal cavity and/or nasal sinus


subject: CHEBI:6970

subject_name: Mometasone


subject: PUBCHEM.COMPOUND:20734893

subject_name: Fluticasone furoate

object_name: Atopic rhinitis


subject: PUBCHEM.COMPOUND:20734893

object_name: Allergic Rhinitis, CTCAE


subject: UMLS:C5239047

subject_name: Anhydrous Enol-oxaloacetate

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C5239047

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C5239047

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C5239047

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C5239047

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C5239047

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: UMLS:C5239047

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UMLS:C5239047

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: UMLS:C5239047

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UMLS:C5239047

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C5239047

object_name: Early Stage Breast Carcinoma


subject: UMLS:C5239047

object_name: Anatomic Stage 0 Breast Cancer AJCC v8


subject: UMLS:C5239047

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UMLS:C5239047

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C5239047

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: UMLS:C5239047

object_name: Prognostic Stage 0 Breast Cancer AJCC v8


subject: UMLS:C5239047

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:30744

subject_name: OXALOACETATE

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:30744

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:30744

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:30744

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:30744

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:30744

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:30744

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:30744

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:30744

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:30744

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:30744

object_name: Early Stage Breast Carcinoma


subject: CHEBI:30744

object_name: Anatomic Stage 0 Breast Cancer AJCC v8


subject: CHEBI:30744

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:30744

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:30744

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:30744

object_name: Prognostic Stage 0 Breast Cancer AJCC v8


subject: CHEBI:30744

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: UMLS:C1366262

subject_name: Hyperimmune Colostrum

object_name: Neck Carcinoma


subject: UMLS:C1366262

object_name: head and neck neoplasm


subject: UMLS:C1366262

object_name: head and neck cancer


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Repeated implantation failure


subject: CHEBI:2549

subject_name: Albuterol

object_name: end stage renal failure


subject: CHEBI:2549

object_name: chronic kidney disease


subject: CHEBI:2549

object_name: Chronic uremia


subject: CHEBI:2549

object_name: Hyperkalemia, CTCAE


subject: CHEBI:2549

object_name: Hyperkalemia


subject: CHEBI:27732

subject_name: Caffeine

object_name: Apnea


subject: CHEBI:27732

object_name: Apnea, CTCAE


subject: CHEBI:174615

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:28901

subject_name: Busulfan


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: UNII:QMS40680K6

subject_name: Palifermin


subject: UNII:QMS40680K6

object_name: acute myeloid leukemia


subject: UMLS:C4724865

subject_name: Trastuzumab Conjugate BI-CON-02

object_name: Carcinoma breast stage IV


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Fatty Liver


subject: UMLS:C5555581

subject_name: Inetetamab

object_name: Childhood Breast Carcinoma


subject: UMLS:C5555581

object_name: breast carcinoma


subject: UMLS:C5555581

object_name: breast cancer


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Hypercholesterolemia


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: temporal arteritis


subject: CHEBI:17650

object_name: polymyalgia rheumatica


subject: UNII:3765U8A1EC

subject_name: Nolasiban

object_name: infertility


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: brain neoplasm


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: anemia


subject: CHEBI:3770

object_name: Anemia, CTCAE


subject: CHEBI:3770

object_name: leukopenia


subject: CHEBI:3770

object_name: neutropenia


subject: CHEBI:3770

object_name: AIDS


subject: CHEBI:3770

object_name: HIV infection


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: pulmonary tuberculosis


subject: CHEBI:63598

subject_name: Levofloxacin


subject: PR:000012224

subject_name: glycodelin

object_name: Constipation


subject: PR:000012224

object_name: Constipation, CTCAE


subject: UNII:9U7D5QH5AE

subject_name: LACTULOSE


subject: UNII:9U7D5QH5AE


subject: PUBCHEM.COMPOUND:21873174

subject_name: Testosterone undecanoate

object_name: hypogonadism


subject: CHEBI:119915

subject_name: Fentanyl

object_name: chronic obstructive pulmonary disease


subject: UMLS:C4310002

object_name: hepatitis C


subject: UMLS:C4310002

object_name: chronic hepatitis C virus infection


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: cystic fibrosis


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Hematoma, Subdural, Chronic


subject: UNII:OWK8BG0FO6

object_name: carcinoma


subject: UMLS:C4725831

subject_name: Anti-CD40 Agonist Monoclonal Antibody CDX-1140


subject: CHEBI:90881

subject_name: Camptosar

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:90881

object_name: Embolism, Tumor


subject: CHEBI:90881

object_name: Neoplasm Metastasis


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:3223

subject_name: Buspirone

object_name: cocaine dependence


subject: CHEBI:8871

subject_name: Risperidone


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: periventricular leukomalacia


subject: PUBCHEM.COMPOUND:92043599

object_name: retinopathy of prematurity


subject: PUBCHEM.COMPOUND:92043599

object_name: exudative vitreoretinopathy 1


subject: PUBCHEM.COMPOUND:92043599

object_name: Retinopathy of Prematurity, AE


subject: PUBCHEM.COMPOUND:92043599

object_name: Intraventricular hemorrhage


subject: UMLS:C0376541

subject_name: Recombinant Erythropoietin


subject: UMLS:C0376541


subject: UMLS:C0376541


subject: UMLS:C0376541


subject: UMLS:C0376541


subject: UMLS:C0302609

subject_name: Xanthine Oxidase Inhibitors

object_name: Hyperuricemia


subject: UMLS:C0302609

object_name: Hyperuricemia, CTCAE


subject: UMLS:C0302609

object_name: gout


subject: UMLS:C3536757

subject_name: Xanthine Oxidase Inhibitor [EPC]


subject: UMLS:C3536757


subject: UMLS:C3536757


subject: UMLS:C3536840

subject_name: Nonsteroidal Anti-inflammatory Drug [EPC]


subject: UMLS:C3536840


subject: UMLS:C3536840


subject: UNII:1MTK0BPN8V

subject_name: Sotrovimab


subject: UMLS:C5432247


subject: CHEBI:31781

subject_name: Lopinavir

object_name: Coronavinae infectious disease


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:177298

object_name: peritoneum cancer


subject: CHEBI:177298

object_name: ovarian adenocarcinoma


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: UNII:HX101E7L6S

subject_name: oregovomab

object_name: Recurrent ovarian cancer


subject: UNII:HX101E7L6S

object_name: Recurrent Fallopian Tube Carcinoma


subject: UNII:HX101E7L6S


subject: UNII:HX101E7L6S


subject: UMLS:C0664206

subject_name: Ovarex


subject: UMLS:C0664206


subject: UMLS:C0664206


subject: UMLS:C0664206


subject: UNII:S4M959U2IJ

subject_name: Teplizumab

object_name: type 1 diabetes mellitus 1


subject: UNII:S4M959U2IJ

object_name: type 1 diabetes mellitus


subject: UMLS:C5206629

subject_name: Multi-kinase Inhibitor TT-00420

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C5206629

object_name: clear cell renal carcinoma


subject: UMLS:C5206629

object_name: urothelial carcinoma


subject: UMLS:C5206629

object_name: transitional cell carcinoma


subject: GTOPDB:12989

subject_name: toripalimab


subject: GTOPDB:12989


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C5433690

subject_name: RC28-E protein

object_name: Wet age-related macular degeneration


subject: PR:000010535

subject_name: kinesin-like protein KIF20B

object_name: bladder tumor


subject: PR:000010535

object_name: urinary bladder carcinoma


subject: PR:000010535

object_name: urinary bladder cancer


subject: PR:000010535

object_name: childhood bladder carcinoma


subject: UMLS:C5226991

object_name: Adult growth hormone deficiency


subject: CHEBI:151315

subject_name: Heparin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:151315

object_name: obesity


subject: CHEBI:151315

object_name: Obesity, CTCAE


subject: GTOPDB:6803

subject_name: dalteparin


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UMLS:C3896902

object_name: Myelodysplasia


subject: CHEBI:15365

subject_name: Aspirin

object_name: colorectal adenoma


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: CHEBI:36796

subject_name: duloxetine

object_name: osteoarthritis


subject: CHEBI:43602

subject_name: Obeticholic acid


subject: CHEBI:43602

object_name: Compensated cirrhosis


subject: CHEBI:49140

object_name: Childhood Breast Carcinoma


subject: CHEBI:49140

object_name: breast carcinoma


subject: CHEBI:49140

object_name: breast cancer


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:31617


subject: UNII:3I798OGQ8B

subject_name: Fluorofuranylnorprogesterone F-18


subject: UNII:3I798OGQ8B


subject: UNII:3I798OGQ8B


subject: CHEBI:229526

subject_name: Sparsentan

object_name: proteinuria


subject: CHEBI:229526

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:229526

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:229526

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:27470

subject_name: Folic acid

object_name: rheumatoid arthritis


subject: GTOPDB:4985

object_name: SLE (systemic lupus)


subject: GTOPDB:4985

object_name: cytomegalovirus infection


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: GTOPDB:5962

subject_name: dovitinib

object_name: Plexosarcoma


subject: CHEBI:4875

subject_name: Etanercept

object_name: mucocutaneous lymph node syndrome


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: CHEBI:68647

subject_name: Regorafenib

object_name: liver carcinoma


subject: CHEBI:68647

object_name: liver cancer


subject: CHEBI:68647

object_name: Adult Liver Carcinoma


subject: CHEBI:66903

subject_name: Vismodegib


subject: CHEBI:66903


subject: CHEBI:66903


subject: UNII:XRO4566Q4R

subject_name: INTERFERON BETA

object_name: chronic obstructive pulmonary disease


subject: UMLS:C0594372

subject_name: Avonex


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: glioblastoma


subject: CHEBI:4026

object_name: Childhood Glioblastoma


subject: CHEBI:4026

object_name: adult glioblastoma


subject: CHEBI:4026

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:4026

object_name: Recurrent Glioblastoma


subject: CHEBI:4026

object_name: MGMT-Unmethylated Glioblastoma


subject: CHEBI:4026

object_name: EGFR gene mutation


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: UMLS:C5909368

subject_name: Autologous Anti-EGFRvIII synNotch Receptor-induced Anti-EphA2/IL-13Ralpha2 CAR-T Cells


subject: UMLS:C5909368


subject: UMLS:C5909368


subject: UMLS:C5909368


subject: UMLS:C5909368


subject: UMLS:C5909368


subject: UMLS:C5909368


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Severe Sepsis


subject: CHEBI:177650

subject_name: Mapracorat

object_name: atopic conjunctivitis


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Furcation Defects


subject: UMLS:C2054270

subject_name: Tdap vaccine

object_name: tetanus


subject: UMLS:C2054270

object_name: pertussis


subject: UMLS:C2054270

object_name: human papilloma virus infection


subject: UMLS:C2054270

object_name: meningococcal meningitis


subject: CHEBI:46916

subject_name: vinyl acetate

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:46916

object_name: acute myeloid leukemia


subject: UMLS:C5779650


subject: UMLS:C5779650


subject: PUBCHEM.COMPOUND:3844471

subject_name: Irofulven

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:3844471

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:3844471

object_name: malignant pancreatic neoplasm


subject: UMLS:C5433690

subject_name: RC28-E protein

object_name: wet macular degeneration


subject: CHEBI:188719

subject_name: Ertugliflozin

object_name: diastolic heart failure


subject: CHEBI:28741

subject_name: Sodium fluoride

object_name: dental caries


subject: CHEBI:28741

object_name: Caries (morphologic abnormality)


subject: UNII:45I6OFJ8QH

subject_name: Bamlanivimab


subject: GTOPDB:11921

subject_name: bebtelovimab


subject: UNII:8YL4SYR6CU


subject: UNII:N7Q9NLF11I

subject_name: Etesevimab


subject: UMLS:C5418046


subject: UMLS:C2266918

subject_name: Platinum-based Drug [EPC]

object_name: ovarian cancer


subject: UMLS:C2266918

object_name: ovarian neoplasm


subject: UMLS:C2266918

object_name: ovarian carcinoma


subject: UMLS:C2266918

object_name: serous adenocarcinoma


subject: UMLS:C2266918

object_name: serous cystadenocarcinoma


subject: UMLS:C2266918

object_name: BRCA2 gene mutation


subject: UMLS:C2266918

object_name: BRCA1 gene mutation


subject: CHEBI:174615

object_name: AIDS-Related Non-Hodgkin Lymphoma


subject: CHEBI:174615

object_name: AIDS-Related Plasmablastic Lymphoma


subject: CHEBI:174615

object_name: AIDS-Related Primary Effusion Lymphoma


subject: CHEBI:174615

object_name: HIV infection


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:75176

subject_name: Ornidazole

object_name: Chronic constipation


subject: UNII:NY7PTD1862

subject_name: AXALIMOGENE FILOLISBAC

object_name: rectal carcinoma


subject: UNII:NY7PTD1862

object_name: rectal cancer


subject: UNII:NY7PTD1862

object_name: Childhood Rectal Carcinoma


subject: UNII:NY7PTD1862

object_name: anus cancer


subject: UNII:NY7PTD1862

object_name: anal carcinoma


subject: UMLS:C2698199

subject_name: Lovaxin-C


subject: UMLS:C2698199


subject: UMLS:C2698199


subject: UMLS:C2698199


subject: UMLS:C2698199


subject: GTOPDB:5962

subject_name: dovitinib

object_name: Metastatic Renal Cell Carcinoma


subject: GTOPDB:5962

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:50858

subject_name: corticosteroid

object_name: acute graft versus host disease


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: UNII:19J3781LPM

subject_name: Itacitinib


subject: MESH:C518627

object_name: neurodegenerative disease


subject: UNII:BNW5PQ52G1

subject_name: Lumicitabine

object_name: respiratory syncytial virus infectious disease


subject: UMLS:C4045816


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Pancreatic carcinoma stage IVA


subject: CHEBI:4672

subject_name: Docetaxel


subject: UNII:490D9F069T

subject_name: Lanthanum carbonate tetrahydrate

object_name: hyperphosphatemia


subject: UNII:490D9F069T

object_name: Serum phosphate concentrations above normal (finding)


subject: UNII:490D9F069T

object_name: Hyperphosphatemia, CTCAE


subject: UNII:0M78EU4V9H

subject_name: Lanthanum carbonate


subject: UNII:0M78EU4V9H


subject: UNII:0M78EU4V9H


subject: CHEBI:59224

subject_name: Cetrorelix

object_name: infertility


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: brain cancer


subject: CHEBI:17252

subject_name: Hydroxyprogesterone

object_name: preeclampsia


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Respiratory insufficiency


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: endometrium adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: endometrial clear cell adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: endometrial serous adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: endometrial adenosquamous carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage II Uterine Corpus Cancer


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIA Uterine Corpus Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIB Uterine Corpus Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIC Uterine Corpus Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IA Uterine Corpus Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IB Uterine Corpus Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVA Uterine Corpus Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVB Uterine Corpus Cancer AJCC v7


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Helicobacter pylori infection


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: CHEBI:5195

subject_name: furazolidone


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: prostate carcinoma


subject: UNII:6XC1PAD3KF

object_name: prostate cancer


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: HIV infection


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:61080

subject_name: Romidepsin

object_name: mycosis fungoides


subject: CHEBI:61080

object_name: neoplasm


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: CHEBI:5103

subject_name: Flumazenil

object_name: Emergence Delirium


subject: CHEBI:8364

subject_name: Prazosin

object_name: continuous methamphetamine abuse


subject: CHEBI:16349

subject_name: Citrulline

object_name: ventricular septal defect


subject: CHEBI:16349

object_name: atrioventricular septal defect, susceptibility to, 1


subject: CHEBI:16349

object_name: familial atrioventricular septal defect


subject: CHEBI:16349

object_name: atrioventricular septal defect


subject: CHEBI:16349

object_name: atrial septal defect, ostium primum type


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: gout


subject: UMLS:C2718754

subject_name: Ilaris


subject: CHEBI:229221

subject_name: Fruquintinib

object_name: Neoplasm, Residual


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: colorectal cancer


subject: GTOPDB:9592

object_name: colorectal carcinoma


subject: GTOPDB:9592

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:8988

object_name: carcinoma of esophagus


subject: CHEBI:8988

object_name: esophageal cancer


subject: CHEBI:8988

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:8988

object_name: neoplasm of esophagus


subject: CHEBI:8988

object_name: gastroesophageal cancer


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C5963200

subject_name: MDM2 Inhibitor SA53-OS

object_name: Childhood Solid Neoplasm


subject: UMLS:C5963200

object_name: Adult Solid Neoplasm


subject: UMLS:C5963200

object_name: Solid Neoplasm


subject: CHEBI:142432

subject_name: Vericiguat

object_name: Reduced ejection fraction co-occurrent and due to chronic heart failure


subject: PUBCHEM.COMPOUND:166177279

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:166177279

object_name: lymphoma


subject: PUBCHEM.COMPOUND:166177279

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:166177279

object_name: melanoma


subject: PUBCHEM.COMPOUND:166177279


subject: PUBCHEM.COMPOUND:166177279


subject: PUBCHEM.COMPOUND:166177279


subject: PUBCHEM.COMPOUND:166177279

object_name: Advanced cancer


subject: DRUGBANK:DB19148


subject: DRUGBANK:DB19148


subject: DRUGBANK:DB19148


subject: DRUGBANK:DB19148


subject: DRUGBANK:DB19148


subject: DRUGBANK:DB19148


subject: DRUGBANK:DB19148


subject: DRUGBANK:DB19148


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UMLS:C0700599

subject_name: pyrimethamine / sulfadoxine

object_name: anemia


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid

object_name: liver cancer


subject: PUBCHEM.COMPOUND:135402009

object_name: liver neoplasm


subject: PUBCHEM.COMPOUND:135402009

object_name: Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:135402009

object_name: liver carcinoma


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: Myeloblastic leukemia


subject: UNII:8M7YSN2KII

object_name: acute myelomonocytic leukemia M4


subject: UNII:8M7YSN2KII

object_name: Myelodysplasia


subject: UNII:8M7YSN2KII

object_name: Adult Myelodysplastic Syndrome


subject: UNII:8M7YSN2KII

object_name: childhood myelodysplastic syndrome


subject: UNII:8M7YSN2KII

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:8M7YSN2KII

object_name: acute lymphoblastic leukemia


subject: UNII:8M7YSN2KII

object_name: non-Hodgkin lymphoma


subject: UNII:8M7YSN2KII

object_name: acute biphenotypic leukemia


subject: UNII:8M7YSN2KII

object_name: acute leukemia of ambiguous lineage


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:73604


subject: MESH:C000728630

object_name: dengue disease


subject: CHEBI:50169

subject_name: Brexanolone

object_name: Maternity blues


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Effects of chemotherapy


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: differentiated thyroid carcinoma


subject: CHEBI:72317

object_name: Refractory Differentiated Thyroid Gland Carcinoma


subject: CHEBI:72317

object_name: poorly differentiated thyroid gland carcinoma


subject: CHEBI:72317

object_name: Refractory Thyroid Gland Carcinoma


subject: CHEBI:72317

object_name: thyroid gland follicular carcinoma


subject: CHEBI:72317

object_name: tall cell variant thyroid gland papillary carcinoma


subject: CHEBI:72317

object_name: follicular variant thyroid gland papillary carcinoma


subject: CHEBI:72317

object_name: thyroid gland papillary carcinoma


subject: CHEBI:72317

object_name: thyroid Hurthle cell carcinoma


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: myocardial infarction


subject: CHEBI:39548

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:39548

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:39548

object_name: peripheral vascular disease


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: skin neoplasm


subject: CHEBI:25681

object_name: skin cancer


subject: CHEBI:12777

subject_name: Vitamin A

object_name: glycogen storage disease II


subject: CHEBI:12777

object_name: age-related macular degeneration


subject: UMLS:C5206815

object_name: cervical cancer


subject: UMLS:C5206815

object_name: cervical carcinoma


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: interstitial cystitis


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: UNII:3VHF2ZD92J

subject_name: Romosozumab

object_name: osteogenesis imperfecta


subject: MESH:C000626184

object_name: Hot Flashes, CTCAE


subject: MESH:C000626184

object_name: Hot flashes


subject: MESH:C000626184

object_name: vasomotor symptom


subject: CHEBI:229213

subject_name: Elacestrant


subject: CHEBI:229213


subject: CHEBI:229213


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Surgical Wound Infection


subject: CHEBI:177833

subject_name: Cilengitide

object_name: adult glioblastoma


subject: CHEBI:177833

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:177833

object_name: Adult Gliosarcoma


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: PUBCHEM.COMPOUND:25127414

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:25127414

object_name: acute myeloid leukemia


subject: UNII:0ICW2LX8AS

subject_name: Bemcentinib


subject: UNII:0ICW2LX8AS


subject: CHEBI:80630

subject_name: Irinotecan

object_name: Advanced cancer


subject: CHEBI:80630

object_name: Drug usage


subject: CHEBI:80630

object_name: Drug use history


subject: CHEBI:80630

object_name: Encounter due to drug use


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: pancreatic adenocarcinoma


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: GTOPDB:12966

subject_name: cadonilimab


subject: GTOPDB:12966


subject: GTOPDB:12966


subject: GTOPDB:12966


subject: GTOPDB:12966


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UMLS:C4727210


subject: UMLS:C4727210


subject: UMLS:C4727210


subject: CHEBI:231679

subject_name: ipilimumab

object_name: pleural sarcomatoid mesothelioma


subject: CHEBI:231679

object_name: pleural biphasic mesothelioma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Intraoperative Hemorrhage


subject: CHEBI:94518

object_name: Childhood Breast Carcinoma


subject: CHEBI:94518

object_name: breast carcinoma


subject: CHEBI:94518

object_name: breast cancer


subject: PUBCHEM.COMPOUND:91971820

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:91971820

object_name: obesity


subject: PUBCHEM.COMPOUND:91971820

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:91971820

object_name: HIV infection


subject: UMLS:C1570976


subject: UMLS:C1570976


subject: UMLS:C1570976


subject: UMLS:C1570976


subject: CHEBI:59524

subject_name: lipoarabinomannan

object_name: osteoarthritis, knee


subject: CHEBI:63577

subject_name: Lamivudine


subject: PR:000034444

subject_name: L-lysine 2,3-aminomutase


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:31355

object_name: Ovarian cancer stage IV


subject: CHEBI:31355

object_name: ovarian carcinosarcoma


subject: CHEBI:31355

object_name: Ovarian cancer stage III


subject: CHEBI:31355

object_name: Stage III Ovarian Cancer AJCC v8


subject: CHEBI:31355

object_name: infectious disease


subject: CHEBI:31355

object_name: leukopenia


subject: CHEBI:31355

object_name: neutropenia


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: primary peritoneal carcinoma


subject: UNII:3A58010674

object_name: papillary serous cystadenocarcinoma


subject: UNII:3A58010674

object_name: peritoneal carcinoma


subject: UNII:3A58010674

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674

object_name: fallopian tube carcinoma


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: acute lymphoblastic leukemia


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:17553

object_name: atopic eczema


subject: CHEBI:71464

subject_name: Palmidrol


subject: UMLS:C1572795

subject_name: PEA Preparation


subject: CHEBI:18397

subject_name: Phenethylamine


subject: DRUGBANK:DB10551

subject_name: Pea


subject: CHEBI:70839

subject_name: Dasatinib

object_name: plasma cell myeloma


subject: CHEBI:190514


subject: CHEBI:49375


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Metastatic Cutaneous Melanoma


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:4026

object_name: Melanoma recurrent


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Rotator Cuff Injuries


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: CHEBI:50847

subject_name: immunological adjuvant

object_name: Clostridium difficile colitis


subject: CHEBI:50847

object_name: clostridium difficile infection


subject: CHEBI:50847

object_name: diarrhea


subject: CHEBI:50847

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:50847

object_name: Diarrhea, CTCAE


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:201431

object_name: clear cell renal carcinoma


subject: CHEBI:201431

object_name: childhood kidney cell carcinoma


subject: CHEBI:201431

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:201431

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:201431

object_name: Papillary renal cell carcinoma type 2


subject: CHEBI:201431

object_name: hereditary papillary renal cell carcinoma


subject: CHEBI:201431

object_name: kidney medullary carcinoma


subject: CHEBI:201431

object_name: collecting duct carcinoma


subject: CHEBI:201431

object_name: Progression of Multiple Myeloma or Plasma Cell Leukemia


subject: CHEBI:201431

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:201431

object_name: Adult Acute Myeloid Leukemia in Remission


subject: CHEBI:201431

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: CHEBI:201431

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:201431

object_name: chronic myelomonocytic leukemia


subject: CHEBI:201431

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:201431

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: CHEBI:201431

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:201431

object_name: Untreated Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:201431

object_name: Childhood Acute Lymphoblastic Leukemia in Remission


subject: CHEBI:201431

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:201431

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:201431

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:201431

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:201431

object_name: childhood myelodysplastic syndrome


subject: CHEBI:201431

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:201431

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:201431

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:201431

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:201431

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:201431

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:201431

object_name: Myelodysplastic syndrome with low blasts (disorder)


subject: CHEBI:201431

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: CHEBI:4031

subject_name: Cyclosporine

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:4031

object_name: clear cell renal carcinoma


subject: CHEBI:4031

object_name: childhood kidney cell carcinoma


subject: CHEBI:4031

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:4031

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:4031

object_name: Papillary renal cell carcinoma type 2


subject: CHEBI:4031

object_name: hereditary papillary renal cell carcinoma


subject: CHEBI:4031

object_name: kidney medullary carcinoma


subject: CHEBI:4031

object_name: collecting duct carcinoma


subject: CHEBI:4031

object_name: Progression of Multiple Myeloma or Plasma Cell Leukemia


subject: CHEBI:4031

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:4031

object_name: Adult Acute Myeloid Leukemia in Remission


subject: CHEBI:4031

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: CHEBI:4031

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:4031

object_name: chronic myelomonocytic leukemia


subject: CHEBI:4031

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:4031

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: CHEBI:4031

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:4031

object_name: Untreated Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:4031

object_name: Childhood Acute Lymphoblastic Leukemia in Remission


subject: CHEBI:4031

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:4031

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:4031

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:4031

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:4031

object_name: childhood myelodysplastic syndrome


subject: CHEBI:4031

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:4031

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:4031

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:4031

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:4031

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:4031

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:4031

object_name: Myelodysplastic syndrome with low blasts (disorder)


subject: CHEBI:4031

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: nonpapillary renal cell carcinoma


subject: PUBCHEM.COMPOUND:3368

object_name: clear cell renal carcinoma


subject: PUBCHEM.COMPOUND:3368

object_name: childhood kidney cell carcinoma


subject: PUBCHEM.COMPOUND:3368

object_name: Metastatic Renal Cell Carcinoma


subject: PUBCHEM.COMPOUND:3368

object_name: Metastatic Renal Cell Cancer


subject: PUBCHEM.COMPOUND:3368

object_name: Papillary renal cell carcinoma type 2


subject: PUBCHEM.COMPOUND:3368

object_name: hereditary papillary renal cell carcinoma


subject: PUBCHEM.COMPOUND:3368

object_name: kidney medullary carcinoma


subject: PUBCHEM.COMPOUND:3368

object_name: collecting duct carcinoma


subject: PUBCHEM.COMPOUND:3368

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: PUBCHEM.COMPOUND:3368

object_name: juvenile myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: chronic myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: Previously Treated Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:3368

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: Untreated Childhood Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: Childhood Acute Lymphoblastic Leukemia in Remission


subject: PUBCHEM.COMPOUND:3368

object_name: recurrent childhood acute myeloid leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: myelodysplastic syndrome with ring sideroblasts


subject: PUBCHEM.COMPOUND:3368

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: De Novo Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:3368

object_name: Myelodysplastic syndrome with low blasts (disorder)


subject: PUBCHEM.COMPOUND:3368

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: CHEBI:63599

subject_name: Fludarabine

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:63599

object_name: clear cell renal carcinoma


subject: CHEBI:63599

object_name: childhood kidney cell carcinoma


subject: CHEBI:63599

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:63599

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:63599

object_name: Papillary renal cell carcinoma type 2


subject: CHEBI:63599

object_name: hereditary papillary renal cell carcinoma


subject: CHEBI:63599

object_name: kidney medullary carcinoma


subject: CHEBI:63599

object_name: collecting duct carcinoma


subject: CHEBI:63599

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: CHEBI:63599

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:63599

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: CHEBI:63599

object_name: Untreated Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:63599

object_name: Childhood Acute Lymphoblastic Leukemia in Remission


subject: CHEBI:63599

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:63599

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:63599

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:63599

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:63599

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:63599

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:63599

object_name: Myelodysplastic syndrome with low blasts (disorder)


subject: CHEBI:63599

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:168396

object_name: clear cell renal carcinoma


subject: CHEBI:168396

object_name: childhood kidney cell carcinoma


subject: CHEBI:168396

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:168396

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:168396

object_name: Papillary renal cell carcinoma type 2


subject: CHEBI:168396

object_name: hereditary papillary renal cell carcinoma


subject: CHEBI:168396

object_name: kidney medullary carcinoma


subject: CHEBI:168396

object_name: collecting duct carcinoma


subject: CHEBI:168396

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:168396

object_name: Adult Acute Myeloid Leukemia in Remission


subject: CHEBI:168396

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: CHEBI:168396

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:168396

object_name: chronic myelomonocytic leukemia


subject: CHEBI:168396

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:168396

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: CHEBI:168396

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:168396

object_name: Untreated Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:168396

object_name: Childhood Acute Lymphoblastic Leukemia in Remission


subject: CHEBI:168396

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:168396

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:168396

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:168396

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:168396

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:168396

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:168396

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:168396

object_name: Myelodysplastic syndrome with low blasts (disorder)


subject: CHEBI:168396

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: CHEBI:8764

subject_name: Mycophenolate mofetil

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:8764

object_name: clear cell renal carcinoma


subject: CHEBI:8764

object_name: childhood kidney cell carcinoma


subject: CHEBI:8764

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:8764

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:8764

object_name: Papillary renal cell carcinoma type 2


subject: CHEBI:8764

object_name: hereditary papillary renal cell carcinoma


subject: CHEBI:8764

object_name: kidney medullary carcinoma


subject: CHEBI:8764

object_name: collecting duct carcinoma


subject: CHEBI:8764

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:8764

object_name: Adult Acute Myeloid Leukemia in Remission


subject: CHEBI:8764

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: CHEBI:8764

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:8764

object_name: chronic myelomonocytic leukemia


subject: CHEBI:8764

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:8764

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: CHEBI:8764

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:8764

object_name: Untreated Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:8764

object_name: Childhood Acute Lymphoblastic Leukemia in Remission


subject: CHEBI:8764

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:8764

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:8764

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:8764

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:8764

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:8764

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:8764

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:8764

object_name: Myelodysplastic syndrome with low blasts (disorder)


subject: CHEBI:8764

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: UMLS:C1570551

object_name: Depressed mood


subject: UMLS:C1570551

object_name: Cancer patients and suicide and depression


subject: UMLS:C1570551

object_name: Depressed - symptom


subject: UMLS:C1570551

object_name: Depression, CTCAE


subject: UMLS:C1570551

object_name: HIV infection


subject: UMLS:C1570551

object_name: AIDS dementia


subject: PUBCHEM.COMPOUND:343523


subject: PUBCHEM.COMPOUND:343523


subject: PUBCHEM.COMPOUND:343523


subject: PUBCHEM.COMPOUND:343523


subject: PUBCHEM.COMPOUND:343523


subject: PUBCHEM.COMPOUND:343523


subject: CHEBI:49166

subject_name: fluorodopa F 18


subject: CHEBI:49166


subject: CHEBI:49166


subject: CHEBI:49166


subject: CHEBI:49166


subject: CHEBI:49166


subject: CHEBI:164200

subject_name: Triclosan

object_name: Dental Plaque


subject: CHEBI:164200

object_name: gingivitis


subject: UMLS:C0450164

subject_name: dental products fluoride toothpaste


subject: UMLS:C0450164


subject: CHEBI:32914

subject_name: Cetylpyridinium


subject: CHEBI:32914


subject: CHEBI:135933

subject_name: Tin Fluorides


subject: CHEBI:135933


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Small cell lung cancer extensive stage


subject: UNII:52CMI0WC3Y

object_name: Small cell lung cancer limited stage


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:Y2T4ALDEAT


subject: UNII:Y2T4ALDEAT


subject: PUBCHEM.COMPOUND:1971

subject_name: ent-Abacavir

object_name: Aicardi-Goutieres syndrome


subject: CHEBI:421707

subject_name: Abacavir


subject: PR:000023218

subject_name: methionine import ATP-binding protein MetN


subject: CHEBI:63577

subject_name: Lamivudine


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED


subject: CHEBI:10110

subject_name: Zidovudine


subject: CHEBI:161680

subject_name: Aztreonam


subject: UNII:3A3U0GI71G

subject_name: Magnesium oxide

object_name: peripheral vascular disease


subject: UNII:3A3U0GI71G

object_name: peripheral arterial disease


subject: CHEBI:31794

subject_name: magnesium oxide


subject: CHEBI:31794


subject: UMLS:C5827885

subject_name: Abrysvo

object_name: Severe acute respiratory infection


subject: UMLS:C5827885

object_name: respiratory syncytial virus infectious disease


subject: UMLS:C5827885

object_name: viral respiratory tract infection


subject: UMLS:C5827885

object_name: Bronchiolitis, Viral


subject: UMLS:C2347419

object_name: triple-negative breast carcinoma


subject: UMLS:C2347419

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C2347419

object_name: Childhood Breast Carcinoma


subject: UMLS:C2347419

object_name: breast carcinoma


subject: UMLS:C2347419

object_name: breast cancer


subject: UMLS:C2347419

object_name: Carcinoma breast stage IV


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:133021

subject_name: Venetoclax

object_name: Richter syndrome


subject: CHEBI:33359

subject_name: rhodium atom

object_name: pregnancy related


subject: CHEBI:18310

subject_name: alkane


subject: UMLS:C0035403

subject_name: Rh Factors


subject: UMLS:C0302050

subject_name: Antigen in Rh blood group system


subject: UMLS:C0021027

subject_name: Immunoglobulins


subject: GTOPDB:4934

subject_name: G-CSF

object_name: Chagas cardiomyopathy


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:52717

subject_name: Bortezomib

object_name: lupus nephritis


subject: CHEBI:52717

object_name: proteinuria


subject: CHEBI:52717

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:52717

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:52717

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:52717

object_name: Hematuria, CTCAE


subject: CHEBI:52717

object_name: Hematuria


subject: PUBCHEM.COMPOUND:11154555

subject_name: Cariprazine

object_name: bipolar disorder


subject: PUBCHEM.COMPOUND:11154555

object_name: bipolar depression


subject: CHEBI:90933


subject: CHEBI:90933


subject: MESH:C000730996

object_name: Safety Issues


subject: UNII:ZAM5J1ATF2

subject_name: CIBISATAMAB

object_name: metastatic colorectal cancer


subject: UMLS:C3896776

subject_name: cibisatamab


subject: UMLS:C5446567

subject_name: FAP/4-1BB-targeting Fusion Protein RO7122290


subject: CHEBI:90943

subject_name: Osimertinib

object_name: carcinoma


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: childhood central nervous system primitive neuroectodermal neoplasm


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721495

subject_name: Astugenal


subject: PR:000014047

subject_name: eosinophil cationic protein

object_name: hepatitis A


subject: PR:000014047

object_name: hepatitis


subject: PR:000014047

object_name: dermatitis


subject: PR:000014047

object_name: Dermatitis


subject: PR:000014047

object_name: colitis


subject: PR:000014047

object_name: Colitis, CTCAE


subject: CHEBI:94531

subject_name: belinostat

object_name: Unresectable Primary Central Chondrosarcoma


subject: CHEBI:94531

object_name: Metastatic Primary Central Chondrosarcoma


subject: CHEBI:94531

object_name: Locally Advanced Unresectable Primary Central Chondrosarcoma


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: UNII:39IS23Q1EW

subject_name: Cedazuridine


subject: UNII:39IS23Q1EW


subject: UNII:39IS23Q1EW


subject: PUBCHEM.COMPOUND:136924190

subject_name: Guadecitabine


subject: PUBCHEM.COMPOUND:136924190


subject: PUBCHEM.COMPOUND:136924190


subject: CHEBI:63610

subject_name: Misoprostol

object_name: infertility


subject: UMLS:C0021641

subject_name: Insulin

object_name: type 1 diabetes mellitus 1


subject: UMLS:C0021641

object_name: type 1 diabetes mellitus


subject: CHEBI:31932

subject_name: olmesartan

object_name: diabetic kidney disease


subject: CHEBI:31932

object_name: Chronic glomerulonephritis


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:3160

object_name: obesity


subject: CHEBI:3160

object_name: Obesity, CTCAE


subject: CHEBI:3160

object_name: Weight loss


subject: CHEBI:3160

object_name: Weight Loss, CTCAE


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: type 2 diabetes mellitus


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: interstitial cystitis


subject: UNII:2P471X1Z11

object_name: Painful Bladder Syndrome


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: UMLS:C5907931

subject_name: Anti-CD123/Kinesin Spindle Protein Inhibitor Antibody-drug Conjugate VIP943

object_name: precursor B-cell acute lymphoblastic leukemia


subject: UMLS:C5907931

object_name: B-cell acute lymphoblastic leukemia


subject: UMLS:C5907931

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5907931

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:18218213

subject_name: QW


subject: PUBCHEM.COMPOUND:18218213


subject: PUBCHEM.COMPOUND:18218213


subject: PUBCHEM.COMPOUND:18218213


subject: CHEBI:141431

subject_name: Gln-Trp


subject: CHEBI:141431


subject: CHEBI:141431


subject: CHEBI:141431


subject: PUBCHEM.COMPOUND:54676860

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:54676860

object_name: malignant pancreatic neoplasm


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:22651

subject_name: ascorbate


subject: CHEBI:22651


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:167715

subject_name: L-ascorbic acid 2-sulfate


subject: CHEBI:167715


subject: UMLS:C0597418

subject_name: Rotavirus Vaccines

object_name: diarrhea


subject: UMLS:C5397359

subject_name: Vaccine product containing only Rotavirus antigen (medicinal product)


subject: PUBCHEM.COMPOUND:76322320

subject_name: COLISTIN

object_name: Cross Infection


subject: PUBCHEM.COMPOUND:76322320

object_name: Critical Illness


subject: PUBCHEM.COMPOUND:76322320

object_name: Multi-antibiotic resistance


subject: CHEBI:37943

subject_name: colistin


subject: CHEBI:37943


subject: CHEBI:37943


subject: CHEBI:47657

subject_name: Roflumilast

object_name: asthma


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: urticaria


subject: RXCUI:8375

object_name: reported urticaria (physical finding)


subject: RXCUI:8375

object_name: Urticaria, CTCAE


subject: CHEBI:50730

subject_name: Montelukast

object_name: bronchiolitis


subject: CHEBI:231614

subject_name: Nivolumab

object_name: renal carcinoma


subject: CHEBI:231614

object_name: kidney neoplasm


subject: CHEBI:231614

object_name: kidney cancer


subject: CHEBI:231614

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:231614

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:135307

subject_name: Moxaverine

object_name: ischemia


subject: CHEBI:50733

subject_name: nutraceutical

object_name: nicotine dependence - cigarettes - with withdrawal


subject: UMLS:C3827048

subject_name: PolyMVA

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C3827048

object_name: amyotrophic lateral sclerosis


subject: CHEBI:75929

object_name: schizophrenia


subject: CHEBI:40009

subject_name: Cycloserine


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: brain ischemia


subject: CHEBI:86285

object_name: primary focal segmental glomerulosclerosis


subject: PUBCHEM.COMPOUND:53394576


subject: UMLS:C0306911

subject_name: Naftin Cream 1%

object_name: tinea cruris


subject: UNII:25E79B5CTM

subject_name: Denileukin diftitox

object_name: adult T-cell leukemia/lymphoma


subject: UMLS:C0211023


subject: UMLS:C0722264

subject_name: Ontak


subject: CHEMBL.COMPOUND:CHEMBL4594472

object_name: Metastatic Digestive System Neuroendocrine Tumor G1